AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17972377
Drug: Implantable Cardioverter-Defibrillator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable Cardioverter-Defibrillator (ICD) therapy
Trial: 17972377
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy for primary prevention
Trial: 17972377
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy for secondary prevention
Trial: 15814547
Drug: Tacrolimus (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus (0.2 mg/kg/day p.o.)
Trial: 15814547
Drug: Cyclosporin-ME (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin-ME (7 mg/kg/day p.o.)
Trial: 11823896
Drug: Chromium treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chromium treatment (400 microg daily)
Trial: 361057
Drug: Fenoprofen 200
RxNorm normalized name: fenoprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoprofen 200 mg and Paracetamol 500 mg (combination)
Trial: 361057
Drug: Fenoprofen 200
RxNorm normalized name: fenoprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoprofen 200 mg (separate)
Trial: 361057
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg (separate)
Trial: 30701554
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of green cardamom for 10 weeks
Trial: 25439709
Drug: Mirror therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirror therapy supported by telerehabilitation
Trial: 25439709
Drug: Traditional mirror
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional mirror therapy
Trial: 19628486
Drug: Supervised exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised exercise intervention (30 min continuous moderate intensity cycle ergometry, twice weekly for 6 weeks)
Trial: 9646891
Drug: Nicotine (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (administered via dermal patch)
Trial: 7923540
Drug: Drug prescriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug prescriptions for diabetic patients
Trial: 7923540
Drug: Drug prescriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug prescriptions for non-diabetic patients
Trial: 2800576
Drug: Butorphanol 2
RxNorm normalized name: butorphanol 2 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 2 mg plus diazepam 10 mg
Trial: 337758
Drug: Amipaque 290
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amipaque 290 mg I/ml
Trial: 337758
Drug: Urografin 60%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urografin 60% (292 mg I/ml)
Trial: 27335145
Drug: Topical rose
RxNorm normalized name: Rose Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical rose oil (in the carrier of almond oil)
Trial: 26054452
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual and hypnosis (TAU+HYP)
Trial: 23241726
Drug: 0.6 µg·kg·min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 µg·kg·min remifentanil
Trial: 23241726
Drug: 0.9 µg·kg·min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 µg·kg·min remifentanil
Trial: 23241726
Drug: 0.3 µg·kg·min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 µg·kg·min remifentanil
Trial: 21880278
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive pills (OC)
Trial: 16636217
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg subcutaneously once a week for 4 weeks
Trial: 15257811
Drug: 17 alpha-hydroxyprogesterone
RxNorm normalized name: 17 alpha-hydroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 alpha-hydroxyprogesterone caproate (17-HPC) administered intramuscularly (341 mg every 3 days)
Trial: 15257811
Drug: Intra-vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-vaginal progesterone (90 mg daily)
Trial: 11169254
Drug: HLA-G*01011 allele
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HLA-G*01011 allele
Trial: 11169254
Drug: HLA-G*01012 allele
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HLA-G*01012 allele
Trial: 11169254
Drug: HLA-G*01013 allele
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HLA-G*01013 allele
Trial: 11169254
Drug: HLA-G*01041 allele
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HLA-G*01041 allele
Trial: 9484876
Drug: grepafloxacin, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: grepafloxacin, 600 mg od
Trial: 9484876
Drug: amoxycillin, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxycillin, 500 mg tds
Trial: 23257680
Drug: Nebulized beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized beclomethasone dipropionate (nBDP) 800 µg, administered twice daily for 4 weeks
Trial: 17684134
Drug: Combination botanical
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination botanical supplement (Curcuma longa, Cynara scolymus, Rosmarinus officinalis, Schisandra chinensis, Silybum marinum, and Taraxacum officinalis; n = 15)
Trial: 17684134
Drug: Dietary changes
RxNorm normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Canges XP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary changes (3 servings/d crucifers or dark leafy greens, 30 g/d fiber, 1‐2 liters/d water, and limiting caffeine and alcohol consumption to 1 serving each/wk; n = 10)
Trial: 27707640
Drug: Burn Cool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Burn Cool Spray®
Trial: 3284421
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg adrenaline
Trial: 3284421
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg adrenaline
Trial: 3284421
Drug: Vasoconstrictors (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasoconstrictors (0.15 mg clonidine or 0.4 mg adrenaline)
Trial: 27541270
Drug: Immediate ibuprofen
RxNorm normalized name: ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Immediate ibuprofen (IIBU)
Trial: 27541270
Drug: Delayed ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Delayed ibuprofen (DIBU)
Trial: 27541270
Drug: No ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: No ibuprofen (NIBU)
Trial: 27541270
Drug: Paracetamol (IPARA)
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol (IPARA)
Trial: 27541270
Drug: Delayed paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed paracetamol (DPARA)
Trial: 27541270
Drug: No paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No paracetamol (NPARA)
Trial: 23275387
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg prednisolone daily for 2 years (P-group)
Trial: 19028705
Drug: Oral nicotinamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nicotinamide (1500 or 500 mg daily for 1 week)
Trial: 19028705
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered for 1 week)
Trial: 9923984
Drug: Homeopathic preparation
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic preparation 'Tinnitus' (D60 potency)
Trial: 7828257
Drug: Flumazenil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.1 mg.ml‐1)
Trial: 31406237
Drug: Desloratadine treatment
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine treatment
Trial: 24242902
Drug: EMD 525797
RxNorm normalized name: Emdisterone
DrugBank: Drostanolone propionate (DB14655)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMD 525797 (DI17E6) 35, 100, 250, 500, 1000, or 1500 mg
Trial: 22042368
Drug: Adjuvant aromatase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant aromatase inhibitor therapy
Trial: 17693918
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule of insulin
Trial: 10223935
Drug: Penciclovir (PCV)
RxNorm normalized name: Penciclovir
DrugBank: Penciclovir (DB00299)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penciclovir (PCV) 5 mg/kg every 12 hours (q12h)
Trial: 10223935
Drug: Penciclovir (PCV)
RxNorm normalized name: Penciclovir
DrugBank: Penciclovir (DB00299)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penciclovir (PCV) 5 mg/kg every 8 hours (q8h)
Trial: 10223935
Drug: Acyclovir (ACV)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir (ACV) 5 mg/kg every 8 hours (q8h)
Trial: 10150324
Drug: Ampicillin/sulbactam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin/sulbactam (1 g + 0.5 g)
Trial: 2142172
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (triethanolamine and aqueous cream)
Trial: 368364
Drug: Cephalosporin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalosporin therapy
Trial: 31113338
Drug: Shorter time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter time to treatment
Trial: 25721698
Drug: 100 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 μg vitamin D3 daily
Trial: 25721698
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg vitamin D3 daily
Trial: 20807322
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg on-demand vardenafil ODT
Trial: 19491798
Drug: Sinupret in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinupret in age-adjusted doses
Trial: 17261211
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of Ondansetron 150 microg kg‐1 intravenously, second dose after 6 h (Group 3)
Trial: 7933819
Drug: Pulse oral
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse oral calcitriol (2 micrograms thrice weekly, increased to 4 micrograms as tolerated)
Trial: 7933819
Drug: Intravenous calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous calcitriol (2 micrograms thrice weekly, increased to 4 micrograms as tolerated)
Trial: 7933819
Drug: Both pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both pulse oral and intravenous calcitriol
Trial: 2952091
Drug: Regular cigarette
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular cigarette (nicotine content: 1.1 mg)
Trial: 2952091
Drug: Light cigarette
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light cigarette (nicotine content: 0.6 mg)
Trial: 29807477
Drug: belimumab 200
RxNorm normalized name: belimumab 200 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: belimumab 200 mg SC
Trial: 10427455
Drug: Intercostal blocks
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intercostal blocks (ICB) with 5 ml 0.5% bupivacaine at the end of surgery and 6 h later
Trial: 10427455
Drug: Interpleural analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpleural analgesia (IPA) with 20 ml 0.25% bupivacaine applied every 4 h using a catheter
Trial: 29852877
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and Root Planing (SRP) followed by subgingival application of curcumin gel
Trial: 24999785
Drug: Routine Fe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine Fe (n 2184; 60 mg ferrous sulfate plus 400 μg folic acid daily throughout pregnancy)
Trial: 24999785
Drug: Selective Fe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective Fe (n 2142; screening and treatment for anaemia and daily intake of 1 mg folic acid)
Trial: 18473021
Drug: Oral‐B Exceed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral‐B Exceed
Trial: 15368824
Drug: Falls prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Falls prevention service intervention (falls risk assessment and evidence-based prescription to GP)
Trial: 8256898
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg ciprofloxacin daily for 7 days
Trial: 8256898
Drug: 300 ng
RxNorm normalized name: NG
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 ng isoniazid daily for 7 days
Trial: 19001206
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation 1200 mg/d
Trial: 19001206
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation 600 mg/d
Trial: 1650526
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy (HFX) at 69.6 Gy
Trial: 31308262
Drug: ropivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine with clonidine 75 µg
Trial: 31308262
Drug: ropivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine with dexamethasone 8 mg
Trial: 31308262
Drug: ropivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine with buprenorphine 300 µg
Trial: 26720443
Drug: ONO-9054 30.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-9054 30.0 μg/mL
Trial: 26720443
Drug: ONO-9054 (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-9054 (0.3, 1.0, 3.0, 10.0, 20.0, or 30.0 μg/mL)
Trial: 11791958
Drug: Artemisinin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemisinin (500 mg for adults, 10 mg/kg for children) for 5 days followed by 2 days of placebo (A5)
Trial: 11791958
Drug: Artemisinin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemisinin (500 mg for adults, 10 mg/kg for children) for 7 days (A7)
Trial: 9888619
Drug: Metergoline (serotonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metergoline (serotonin antagonist)
Trial: 2547216
Drug: Mopidamol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mopidamol (2 x mg i.v. daily perioperatively, 3 x 500 mg orally postoperatively)
Trial: 2102668
Drug: Once-daily regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily regimen
Trial: 2102668
Drug: Three-time daily
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Three-time daily regimen
Trial: 27699880
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of UVB nb and UVA (320‐400 nm) phototherapy
Trial: 21332272
Drug: Polymyxin B
RxNorm normalized name: Polymyxin B
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polymyxin B sulfate, neomycin sulfate and gramicidin (PS) ear drops, thrice daily for 10 ± 2 days
Trial: 21332272
Drug: Glycerol ear
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol ear drops, thrice daily for 10 ± 2 days
Trial: 17286197
Drug: Internet administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet administered CHQ-CF questionnaire
Trial: 17286197
Drug: Paper administered
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper administered CHQ-CF questionnaire
Trial: 17286197
Drug: Both internet
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both internet and paper administration
Trial: 14749753
Drug: Fruit juices
RxNorm normalized name: Morinda citrifolia fruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruit juices (1 l daily for 16 weeks)
Trial: 14749753
Drug: Fruit-vegetable-concentrate (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruit-vegetable-concentrate (30 ml daily for 16 weeks)
Trial: 9794841
Drug: Daclizumab (humanized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab (humanized monoclonal antibodies against the IL-2 receptor) added to standard cyclosporin-based immunosuppression
Trial: 2908433
Drug: Epanolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epanolol (100 mg twice daily for 4 weeks)
Trial: 27669373
Drug: 3% sodium
RxNorm normalized name: Dextrose 5% and 0.3% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% sodium bicarbonate saline solution for oral care
Trial: 11866422
Drug: Small volume
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small volume resuscitation fluids (SVR) - a combination of hypertonic crystalloid with a colloid; specific dosage and duration not mentioned.
Trial: 11866422
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline solution (HSD); specific dosage and duration not mentioned.
Trial: 30297322
Drug: 7-day-dose metronidazole
RxNorm normalized name: metronidazole 7.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day-dose metronidazole (500 mg twice daily for 7 days)
Trial: 22830646
Drug: Lunchtime walking
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lunchtime walking intervention in an urban environment, twice a week for 8 weeks
Trial: 22830646
Drug: Lunchtime walking
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lunchtime walking intervention in a natural environment, twice a week for 8 weeks
Trial: 18533183
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg mCPP with ritanserin pre-treatment
Trial: 18533183
Drug: mCPP administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: mCPP administration
Trial: 15674303
Drug: 0.25 g
RxNorm normalized name: AMICAR 0.25 GM/mL Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 g WA
Trial: 15674303
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g WA
Trial: 15674303
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g WA
Trial: 15674303
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g WA (long-term administration)
Trial: 15674303
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g WA (control for long-term administration)
Trial: 12083587
Drug: IV parecoxib
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: IV parecoxib sodium 40 mg
Trial: 12083587
Drug: morphine 4
RxNorm normalized name: morphine 4 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine 4 mg
Trial: 348229
Drug: Cephaloridine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephaloridine (3 doses of 1 g each: 1 g IV at surgery start, 1 g IM at 6 hours, 1 g IM at 12 hours)
Trial: 348229
Drug: Cephaloridine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephaloridine (3 doses of 1 g each)
Trial: 28335798
Drug: Anakinra 100
RxNorm normalized name: ANAKINRA 100MG INJ,SYRINGE,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra 100 mg
Trial: 26768233
Drug: Lifestyle intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lifestyle intervention (dietary counselling twice by telephone and access to twice‐weekly exercise groups)
Trial: 25741842
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml HES 130/0.4
Trial: 25741842
Drug: 1500 ml
RxNorm normalized name: Bag/Pump Set 1500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 ml 9‰ saline solution
Trial: 16091706
Drug: F‐milk (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F‐milk (daily approx. 0.2 l with the level 2.5 ppm)
Trial: 12585183
Drug: Mifepristone and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone and Chinese herbal medicine (CHM)
Trial: 12585183
Drug: Methotrexate and
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate and Chinese herbal medicine (CHM)
Trial: 10941859
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin (BT) 1.2 ml injected endoscopically
Trial: 10941859
Drug: Saline 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline 1.2 ml injected endoscopically (Control)
Trial: 8749123
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose ethanol (0.45 g/kg LBW)
Trial: 8749123
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose ethanol (0.80 g/kg LBW)
Trial: 8749123
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose ethanol (1.05 g/kg LBW)